18 August 2022
: Case report 
Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation
Challenging differential diagnosis, Unusual setting of medical care, Rare disease
Marcel Cerqueira Cesar Machado1ABEF*, Roberto Kalil Filho2E, Ibrahim Ahmad Hussein el Bacha3BF, Irai Santana de Oliveira4CD, Cristiane Maria de Freitas Ribeiro5CD, Heraldo Possolo de Souza1DE, Edson Roberto Parise6CDDOI: 10.12659/AJCR.936250
Am J Case Rep 2022; 23:e936250
Table 2. Laboratory tests during hospital evolution. Data obtained at hospital admission. Peak values and current data for these biochemical evaluations.
| Admission | Peak | Current | |
|---|---|---|---|
| AST/ALT (IU/mL) | 132/92 | 139/32 | 54/5 |
| GGT/ALP (IU/mL) | 625/294 | 2109/2031 | 568/786 |
| Total bilirubin (mg/dL) | 1.89 | 21.72 | 14.22 |
| Creatinine (mg/dL) | 4.03 | 4.03 | 1.677 |
| C-Protein (mg/dL) | 23.95 | 23.95 | 13.67 |
| ALP – alkaline phosphatase. | |||